Add like
Add dislike
Add to saved papers

Unilateral iliac disease: the role of iliofemoral bypass.

This article reviews our experience with iliofemoral bypass during the past 10 years to better define its role in the treatment of unilateral iliac artery occlusive disease. For 50 patients, the cumulative patency rate was 96% +/- 3% at 1 year and 92% +/- 5% at 2 and 3 years. The operation was most likely to be successful if the indication was claudication (p less than 0.05). There was no significant difference when patients with or without profundaplasty were compared. It is concluded that iliofemoral bypass is a durable operation and indicated when transluminal dilatation is not possible and the common iliac artery is suitable as a source of inflow. When indicated, the procedure can be carried out safely for both high- and low-risk patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app